Timely and effective phase III CLINiCAL trials for PTSD
Timely and effective phase III CLINiCAL trials for PTSD
At Anaco34 we are focused on the treatment of PTSD.
On average 34 of our Service Members are taking their lives per day and it must stop
PTSD is a real problem. In a Covid 19 Environment maybe more.
We have a solution that is not based upon the use of anti depressants or psychotropic drugs
We are currently recruiting 1,000 participants in 3 states for this Clinical Drug Trial
If you live in New York City, Fort Bragg NC, or Tampa Florida you may be eligible to participate. The Trial starts in September 2020 and will take 6 months to complete
We are recruiting and enrolling for our Phase III FDA Clinical Trial TODAY. We have extensive team and clinical trial experience in PTSD. We are introducing a new drug to the market
We are using a Stellate Ganglion Block combined with our patented Drug "Clonicaine". We have had an 85% success rate in compassionate care use and are seeking FDA clearance. We have been featured on 60 Minutes and in the Wall Street Journal.
The Stellate Ganglion Block injection takes less than 5 minutes and the results are known immediately. It is painless. The Drug used is called "Clonicaine". Clonicaine is a combination of two FDA approved drugs in a new application which have been used in over 30 years in humans
33% of our study participants will receive a placebo. 33% will get CPT. However EVERYONE will get the "active agent" drug via injection after 30 days upon notification
There is not cost to participate in the Anaco34 Trial. However, there are monthly followup appointments through Telemedicine required for all participants for a period of 6 months from when you are treated
Please send us a message or email us to enroll as a clinical study participant
Monday - Friday: 8:00am - 5:00pm
Saturday - Sunday: Closed
Copyright © 2020 Anaco34 - All Rights Reserved.
Powered by GoDaddy Website Builder